Physician

Lindsay Cunningham, D.O.

According to 2025 Medicare claims, Lindsay Cunningham, D.O. (NPI: 1366709354) practices internal medicine in the Tulsa, OK market, with the plurality of this provider's patient population coming from Tulsa, OK. This provider's primary affiliated billing organization is TULSA RHEUMATOLOGY CLINIC LLC (NPI: 1437802998; TIN: 874058067) and primary practice location at 74114-1738.

Cunningham's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 207 traditional Medicare patients, billed 145,990 HCPCS/CPT codes, and received $1,693,562 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 860 prescription claims across 127 beneficiaries totaling $384,499 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2015 DME data shows 33 claims. Open Payments data shows 1 records totaling $119. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $50,943 to $1,693,562. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$847K$1.7M2017 Medicare payment: $50,943 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $425,416 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $796,877 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,404,562 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,468,223 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $888,500 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $965,329 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,693,562 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017128762$50,943
201831122,754$425,416
201935050,937$796,877
202032390,602$1,404,562
2021297118,589$1,468,223
202227663,760$888,500
202320270,163$965,329
2024207145,990$1,693,562

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$812K$1.6M2015 Drug cost: $30,292 (USD; Tot_Drug_Cst)2016 Drug cost: $25,595 (USD; Tot_Drug_Cst)2017 Drug cost: $52,798 (USD; Tot_Drug_Cst)2018 Drug cost: $420,402 (USD; Tot_Drug_Cst)2019 Drug cost: $830,457 (USD; Tot_Drug_Cst)2020 Drug cost: $1,456,508 (USD; Tot_Drug_Cst)2021 Drug cost: $1,624,516 (USD; Tot_Drug_Cst)2022 Drug cost: $1,163,038 (USD; Tot_Drug_Cst)2023 Drug cost: $392,914 (USD; Tot_Drug_Cst)2024 Drug cost: $384,499 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201580697$30,292
201667309$25,595
201749183$52,798
20181481,247$420,402
20192151,905$830,457
20202522,223$1,456,508
20212532,216$1,624,516
20222391,525$1,163,038
2023125727$392,914
2024127860$384,499

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$211$4222015 Medicare payment: $422 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R33$422
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more4646$131
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more154467$122
96413Administration of chemotherapy into vein, 1 hour or less82531$90
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more70110$79
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's129276$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab21756$186,187
Cosentyx Sensoready (2 Pens)Secukinumab14392$95,842
LeflunomideLeflunomide1408,126$12,527
Hydroxychloroquine SulfateHydroxychloroquine Sulfate21613,048$8,426
MethotrexateMethotrexate Sodium1958,983$6,001

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$119GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Lindsay Cunningham, D.O.?

Tedicare shows public-source Medicare data for Lindsay Cunningham, D.O. (NPI 1366709354), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lindsay Cunningham, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Lindsay Cunningham, D.O.?

Lindsay Cunningham, D.O. is linked to TULSA RHEUMATOLOGY CLINIC LLC (billing NPI 1437802998) in the available physician profile data.

Does Lindsay Cunningham, D.O. have Open Payments data?

Lindsay Cunningham, D.O. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.